arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

download Export Data

LifeStance Health Group, Inc.

LFST

$10.82 ▲ +0.18 (+1.74%) at close

7 Visible periods

29 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Fair

Neutral

auto_awesome

Analytical Summary

LifeStance Health Group, Inc. shows mixed fundamentals. Consider comparing against peers in the Healthcare sector before making investment decisions.

Market Cap $4.2B

Dividend Yield —

Revenue Growth 13.9% ↘

Op. Margin 1.7% ↗

ROIC 1.0% ↗

FCF / Share $0.29 ↗

Trailing P/E —

Price / Book 2.8x

FCF Yield 2.6%

Debt / Equity 0.19

info Valuation on last close. End-of-day price, Aug 7, 2026.

7-Year Financial Trajectory

Annual

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$1.42B

↑ +13.9% —

Net Income Profit after all expenses

$9.66M

↑ +116.8% —

Operating Margin Operating profit as % of sales

1.7%

↑ +167.1% 33th

FCF / Share Free cash flow per share

$0.29

↑ +26.1% —

Long-Term Debt Long-term obligations

$282.75M

↓ -2.5% —

Health Breakdown

Profitability

Returns

Financial Health ↑

Cash Quality ↑

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 5 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Apr 13, 2020 10-K ↗
Revenue Growth YoY (%)	13.9% Good ↓ Good Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+73%)	18.5% Good ↓ Good Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+131%)	22.8% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+185%)	28.8% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+260%)	—	—	—
Net Income Growth YoY (%)	N/M	69.2% Excellent ↑ Excellent Improving Year-over-year change in net income	13.6% Fair Fair Year-over-year change in net income	29.8% Excellent Excellent Year-over-year change in net income	—	—	—
FCF Growth YoY (%)	26.1% Excellent ↓ Excellent Declining Year-over-year change in free cash flow	N/M	99.8% Excellent Excellent Year-over-year change in free cash flow	71.3% Excellent Excellent Year-over-year change in free cash flow	—	—	—
Revenue CAGR 3Y (%)	18.3% Excellent ↓ Excellent Declining Compound annual revenue growth over 3 years	23.3% Excellent Excellent Compound annual revenue growth over 3 years	—	59.3% Excellent Excellent Compound annual revenue growth over 3 years	—	—	—
Revenue CAGR 5Y (%)	—	42.6% Excellent Excellent Compound annual revenue growth over 5 years	—	—	—	—	—

💰 Are margins durable? 5 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Apr 13, 2020 10-K ↗
Operating Margin (%) (%)	1.7% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-89%)	-2.5% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-117%)	-17.9% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-219%)	-24.5% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-263%)	-42.9% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-386%)	—	7.2% Caution Caution Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-52%)
Effective Tax Rate (%) (%)	21.8% Fair ↑ Fair Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.3% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	9.8% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	7.4% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	7.8% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	28.0% Caution Caution Actual taxes paid relative to pre-tax income Optimal: 15-25%
Profit Margin (%) (%)	0.7% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-94%)	-4.6% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-138%)	-17.6% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-247%)	-25.1% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-309%)	-46.0% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-484%)	—	2.7% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-78%)
FCF Margin (%) (%)	7.7% Caution ↑ Caution Improving Free cash flow as a percentage of revenue Optimal: > 10%	6.9% Caution ↑ Caution Improving Free cash flow as a percentage of revenue Optimal: > 10%	-5.4% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-3.1% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-12.7% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	1.3% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%
FCF / Net Income (x)	11.39x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	-1.49x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.31x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	0.12x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.28x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	0.48x Weak Weak Free cash flow relative to reported net income Optimal: > 1x

🎯 Is capital allocation efficient? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Apr 13, 2020 10-K ↗
Return on Invested Capital (%)	1.0% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-1.8% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-9.9% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-11.1% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	-15.5% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	—	—
Return on Capital (%) (%)	1.1% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-1.5% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-9.0% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-9.7% Weak Weak Operating profit relative to total assets Optimal: > 10%	-14.9% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—
Return on Common Equity (%) (%)	0.6% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-96%)	-4.0% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-126%)	-13.0% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-187%)	-14.2% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-195%)	-19.9% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-233%)	—	—

⚖️ Is the balance sheet risky? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Apr 13, 2020 10-K ↗
Debt to Equity (x)	0.19x Excellent → Excellent Stable Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-69%)	0.20x Excellent ↑ Excellent Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-67%)	0.20x Excellent → Excellent Stable Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-66%)	0.15x Excellent ↓ Excellent Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-74%)	0.10x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-83%)	0.37x Good Good Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-38%)	—
Interest Coverage (x)	2.07x Caution ↑ Caution Improving Operating income divided by interest expense Optimal: > 5x	-1.19x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-8.91x Weak → Weak Stable Operating income divided by interest expense Optimal: > 5x	-10.55x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-7.36x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	2.82x Caution Caution Operating income divided by interest expense Optimal: > 5x
Net Debt (USD)	$34.11M	$135.43M	$210.67M	$125.34M	$13.20M	$354.99M	—
Debt / EBITDA (x)	4.30x Weak ↓ Weak Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	31.99x Weak ↑ Weak Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-1.91x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-1.29x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.59x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	—

📊 What does each share earn? 5 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Apr 13, 2020 10-K ↗
Revenue per Share (USD)	$3.69	$3.30	$2.87	$2.42K	$2.04K	—	—
Free Cash Flow per Share (USD)	$0.29	$0.23	$-0.16	$-74.49	$-259.74	—	—
Book Value per Share (USD)	$3.92	$3.78	$3.77	$4.04	$4.13	—	—
Tangible Book Value per Share (USD)	$0.13	$-0.10	$-0.23	$-0.05	$0.11	—	—
Basic Weighted Avg Shares (shares)	386.02M	379.15M	367.46M	355,278	327,523	—	—

🏦 How resilient is the balance sheet? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Apr 13, 2020 10-K ↗
Working Capital (USD)	$164.24M	$83.62M	$22.86M	$57.22M	$149.77M	$359.00K	—
LT Debt (USD)	$282.75M	$290.00M	$289.49M	$233.96M	$161.23M	$373.82M	—
Total Equity (USD)	$1.52B	$1.45B	$1.43B	$1.52B	$1.55B	$997.84M	—

📋 What is driving earnings? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Apr 13, 2020 10-K ↗
Sales/Revenue/Turnover (USD)	$1.42B	$1.25B	$1.06B	$859.54M	$667.51M	—	$212.52M
Depreciation Expense (USD)	$41.62M	$40.68M	$37.37M	$28.92M	$15.09M	—	$3.04M
Net Income, GAAP (USD)	$9.66M	$-57.44M	$-186.26M	$-215.56M	$-307.20M	—	$5.67M
Operating Cash Flow (USD)	$146.15M	$107.26M	$-16.88M	$52.79M	$9.42M	—	$17.05M

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 7 years · 26 quarters

LifeStance Health Group, Inc.

Analytical Summary

7-Year Financial Trajectory

Health Breakdown

Statement lens

Benchmark Lens

Percentile Rankings

Peer Comparison

Compare LFST with peers